Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000005

Director sold 13,500 shares at an average $90.06 ($1,215,853)

  • Director acquired 13,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Golumbeski George · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-11 Exercise or conversion : show line 1 in the form +2,272 $25.58 $58,118 2,272 D
2019-02-11 Sale : show line 2 in the form −2,272 $90.03 $204,552 0 D
2019-02-12 Exercise or conversion : show line 3 in the form +3,728 $25.58 $95,362 3,728 D
2019-02-12 Exercise or conversion : show line 4 in the form +7,500 $29.02 $217,650 11,228 D
2019-02-12 Sale : show line 5 in the form −11,228 $90.07 $1,011,301 0 D
Open-market sales · 13,500 sh · avg $90.06 · $1,215,853

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-02-11 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −2,272 $25.58 2026-02-11 2,272 3,728 D
2019-02-12 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −3,728 $25.58 2026-02-11 3,728 0 D
2019-02-12 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −7,500 $29.02 2027-02-16 7,500 0 D
Loading xslF345X03/edgar.xml…